AvenuesAI Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
CCAVENUE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
AvenuesAI Limited has filed a compliance statement confirming no deviation in the utilisation of proceeds from its Rights Issue dated July 15, 2025. The company raised Rs. 69,998.57 Lakhs through the issue. Out of four allocation heads, funds for subsidiary loan repayment (Rs. 6,984 Lakhs) and Rediff.com investment (Rs. 7,670 Lakhs of Rs. 8,766.40 Lakhs allocated) are largely deployed. The largest allocation of Rs. 29,399.59 Lakhs for AI/technology investment in Nueromind Technologies shows only Rs. 944 Lakhs utilised (~3.2%), suggesting phased deployment. General corporate purposes (Rs. 24,388.58 Lakhs allocated) has seen Rs. 16,933.84 Lakhs deployed. CARE Ratings is the monitoring agency. The Audit Committee and auditors have no comments, indicating standard compliance.
This filing is a routine compliance confirmation with no red flags for shareholders. The low utilisation for AI investment appears deliberate as the company is deploying funds as per stated objects in a phased manner. The company has approximately Rs. 34-35 crore still in hand to deploy across investment heads.